KENDALL MOHLER

Profile

First Name

: KENDALL

Middle Name

:

Last Name

: MOHLER

Related Companies

Titles

Company Name

Related People

EXECUTIVE OFFICER

TRUBION PHARMACEUTICALS, INC

LEE R. BRETTMAN, MICHELLE BURRIS, KATHLEEN M. DEELEY, STEVEN GILLIS, PATRICK HERON, ANDERS D. HOVE, DAVID A. MANN, SAMUEL R. SAKS, DAVID SCHNELL, SCOTT STROMATT, PETER THOMPSON

EXECUTIVE OFFICER

MAGNOLIA NEUROSCIENCES CORP

MICHAEL BARAN, MARGARITA CHAVEZ, BARBARA DALTON, M. JOHNSTON ERWIN, STEVE GILLIS, IAN HOWES, THONG LE, ALICE LY, JOEL MARCUS, DAVID SCHUBERT, ASISH XAVIER

EXECUTIVE OFFICER

RODEO THERAPEUTICS CORP

MARGARITA CHAVEZ, STEVE GILLIS, KATIE HEWITT, IAN HOWES, THONG LE, JOEL MARCUS, SANFORD MARKOWITZ, LINDSAY RAYLE, SUZANNE RETTENMIER, DAVID SCHUBERT, JAMES SULLIVAN, ASISH XAVIER, TADATAKA YAMADA

EXECUTIVE OFFICER, DIRECTOR

KAYOTHERA, INC.

MARK ESPOSITO, JAMES M. GOLUBIESKI, GEORGE F. HEINRICH, IAN HOWES, YIBIN KANG, THONG LE, KEN MOHLER, SUZANNE RETTENMIER

EXECUTIVE OFFICER

AUTOMERA US INC.

SEAN CASSIDY, YU-CHIEH ALICE CHEN, WEN QI HO, IAN HOWES, MITCHELL HYMOWITZ, THONG LE, SUZANNE RETTENMIER, BENJAMIN ZIAN-LOONG WANG

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2023-09-05

D/A

OTHER

DECLINE TO DISCLOSE

Equity

2022-03-11

D/A

OTHER

DECLINE TO DISCLOSE

Equity

2022-03-11

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2020-07-07

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2020-07-07

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2018-11-26

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2018-11-26

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2018-08-03

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2009-09-01